Dergiler / Journal of Health Sciences and Medicine / 2022 / Cilt: 5 - Sayı: 5

The progress of chronic renal disease patients followed by the diagnosis of COVID-19 in ICU

Sayfa
1443–1448
Yayın Tarihi
2022-09-25
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

APACHE II and SOFA scores were higher than the other groups (p=

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: The mortality and morbidity of COVID-19 disease are higher in patients with comorbidities.
📊
Temel Bulgular & Veri:Material and Method: The medical records of 249 patients followed in Ankara City Hospital MH3 ICU were reviewed retrospectively.
💡
Sonuç & Katkı:APACHE II and SOFA scores were higher than the other groups (p=
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:COVID-19 · chronic kidney disease · mortality

Abstract

Aim: The mortality and morbidity of COVID-19 disease are higher in patients with comorbidities. In this study, we staged patients with chronic renal failure hospitalized in the intensive care unit (ICU) and aimed to evaluate the process of the disease according to the stage of failure. Material and Method: The medical records of 249 patients followed in Ankara City Hospital MH3 ICU were reviewed retrospectively. The patients were divided into three stages according to their estimated glomerular filtration rate (e-GFR) value (stage 1: e-GFR≥90 ml/min/1.73 m², stage-2: e-GFR: 15-89 ml/min/1.73 m², stage- 3: e-GFR≤15 ml/min/1.73 m²). Data such as age, gender, comorbidity status, length of stay in the ICU, duration of mechanical ventilation, and mortality rate of the patients were recorded. Patients who were evaluated as stage-2 were also classified into 3 stages (stage-2a: e-GFR: 60-89 ml/min/1.73 m², stage-2b: e-GFR:30-59 ml/min/1.73 m², stage-2c: e-GFR: 15-29 ml/min/1.73 m²) and evaluated with the same parameters. Results: The mean age of all patients was 71 years. It was found that the intubation rate was higher (p=0.012) and the mortality rate was higher (p=0.003) in patients evaluated as stage-3. APACHE II and SOFA scores were higher than the other groups (p=

🔖

Bu Makaleye Atıf Yap

UYSAL, E., SEĞMEN, F., ULUBAŞOĞLU, P., ZENGİN, E. N., ERDEM, D. (2022). The progress of chronic renal disease patients followed by the diagnosis of COVID-19 in ICU. Journal of Health Sciences and Medicine, Cilt: 5 - Sayı: 5, 1443–1448. https://ajindex.com/articles/776476

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Aydemir S, Hoşgün D. The role of serum lipoprotein levels in predicting independent short-term mortality in COVID-19 patients. Anatolian Curr Med J 2022; 4; 162-6. Zengin EN. Research trends and global productivity on mechanical ventilation with the impact of COVID-19: a bibliometric analysis in the period 1980-2021. J Health Sci Med 2022; 5: 1051-61.
  2. Arslan K, Baş S. Frequency of troponin elevations in patients with COVID-19 and clinical course in these patients. Anatolian Curr Med J 2022; 4; 95-102.
  3. Peiris JSM, Chu CM, Cheng VCC. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361: 1767–72.
  4. Zhou P, Yang XL, Wang XG. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-3.
  5. Chu KH, Tsang WK, Tang CS. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int 2005; 67: 698–705.
  6. Wang D, Hu B, Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–9.
  7. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323: 2052–9.
  8. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020; 97: 829–38.
  9. Ülger G, Baldemir R. Analysis of global publications on tracheostomy between 1980 and 2021, including the impact of COVID-19: a bibliometric overview. J Med Palliat Care 2022; 3: 103-10.
  10. Zengin M, Baldemir R. Investigation of the global outcomes of acute respiratory distress syndrome with the effect of covid-19 in publications: a bibliometric analysis between 1980 and 2020. Kırıkkale Üniversitesi Tıp Fakültesi Derg 2021: 23: 279-92.
  11. Zengin M, Karcioglu AM. Do not invade, just support. Bratislavske Lekarske Listy 2022: 123; 218-26.
  12. Baldemir R, Ülger G. A holistic investigation of the global outcomes of spontaneous pneumothorax during 1980-2021, including the COVID-19 pandemic: a bibliometric approach. Medicine (Baltimore) 2022: 101: e29113. Portolés J, Marques M, Sánchez PL, De Valdenebro M, Muñez E, Serrano ML. Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak. Nephrol Dial Transplant 2020; 35: 1353–61.
  13. Cırık MÖ, Baldemir R, Doğanay GE, Ünver M, Avcı S. The 30-day mortality predictor role of c-r